Wockhardt

Wockhardt News

Pharmaceutical sector, Indian pharmaceutical sector, India colombo relations, health news, pharma news,

Glenmark USA continues to expand its Over-The-Counter Portfolio with acquisition of new drugs from Wockhardt Limited

Currently, Glenmark’s portfolio consists of 175 products authorized for distribution in the U.S. marketplace and 48 ANDAs pending approval with…

June 28, 2022 14:02 IST

Wockhardt unit partners with SII subsidiary to set up vaccine manufacturing plant in UK

According to a statement, the collaboration between Wockhardt UK and Serum Life Sciences UK Ltd will help create a considerable…

March 21, 2022 14:40 IST

Rakesh Jhunjhunwala effect: Wockhardt shares jump 6% as big bull emerges among major shareholders

Although it can not be established if this investment into Wockhardt is Rakesh Jhunjhunwala’s initial purchase of the firm’s stocks,…

January 20, 2021 16:08 IST

Wockhardt shares freeze at 10% upper circuit on COVID-19 vaccine collaboration

Wockhardt in a BSE filing said that the manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based…

August 4, 2020 14:55 IST

Top 10 stocks that made news today: Amtek Auto, Unitech, BHEL and more

Amtek Auto Shares ended 5.63 per cent down at Rs 27.65 after the company reported net loss of Rs 132.15…

Updated: February 12, 2016 17:00 IST

US FDA observations for Shendra facility not critical: Wockhardt

According to the company, half of the issues will be resolved in next fortnight The nine observations received by Wockhardt…

January 18, 2016 16:49 IST

USFDA observations for Shendra facility not critical: Wockhardt

The facility, which produces various products including ointments, capsules and tablets, currently caters to the UK and Ireland markets.

January 18, 2016 13:50 IST

USFDA makes 9 observations over Wockhardt’s plant in Aurangabad

The USFDA has made nine ‘observations’ highlighting violations of its norms at homegrown drug maker Wockhardt’s new facility at Shendra…

January 15, 2016 18:22 IST

Wockhardt falls more than 10% on reports over US FDA notice

Wockhardt shares fell as much as 12.69 per cent intraday on Friday on reports the company has received a notice…

Updated: January 15, 2016 16:26 IST

Wockhardt receives QIDP status from US FDA

WCK 5222 is a new class of antibiotic for gram negative terrain for complicated urinary tract infections and HABP/ VABP…

December 9, 2015 09:57 IST

Wockhardt gets QIDP status for new antibiotic product from FDA

Drug maker Wockhardt has received qualified disease product (QIDP) status from US health regulator for a new antibiotic.

December 8, 2015 16:34 IST

Wockhardt’s Chikalthana plant gets GMP certificate from UKMHRA

The UK regulator had in October 2013 withdrawn the GMP certificate to the Chikalthana plant Wockhardt’s Chikalthana plant at Aurangabad…

December 2, 2015 10:15 IST

Wockhardt gets exemption from price control for three insulin products

The three products have been classified as new drugs and thus qualify for non-application of the DPCO 2013 Drug price…

November 24, 2015 10:02 IST

NPPA exempts Wockhardt’s 3 insulin products from price control

Wockhardt had applied to the National Pharmaceutical Pricing Authority (NPPA) for non-application of price control provisions of the DPCO 2013…

November 24, 2015 08:59 IST

Wockhardt posts consolidated revenue of Rs 1231 crore in quarter ended Sept 30, 2015

EBIDTA was at Rs 201 crore

November 16, 2015 10:36 IST

Wockhardt Q2 net zooms to Rs 108 crore

Wockhardt today reported a multi-fold jump in consolidated net profit at Rs 107.59 crore for the second quarter ended September…

November 13, 2015 15:32 IST

Wockhardt shares gain after UK MHRA says no critical observations at drug plant

Wockhardt shares were trading over 2 per cent up after the company said that UK’s health regulator Medicines and Healthcare…

Updated: October 6, 2015 16:39 IST

Why Indian pharma stocks are performing better than their global counterparts

The double-digit stock market gains of Indian pharmaceutical giants including Dr. Reddy’s Laboratories and Wockhardt stand out in stark relief…

September 3, 2015 09:11 IST

Sun Pharma, Wockhardt recall drugs from US market

Sun Pharma’s recall was initiated last month under Class-III classification while Wockhardt’s recall was under class-II classification Sun Pharma and…

August 31, 2015 09:37 IST

Wockhardt’s consolidated revenue for Q1FY16 grows by 15 per cent at Rs1141 crore

EBIDTA is up by 165 per cent at Rs 167 crore Wockhardt has posted its first quarter results for financial…

August 11, 2015 09:13 IST

Wockhardt recalls over 50 lakh bottles of various drugs in US

Wockhardt is recalling over 50 lakh bottles of various drugs, used for treating ailments like high blood pressure and ulcer.

August 4, 2015 10:49 IST

Wockhardt recalls over 1.62 lakh cartons of drugs in US

Drug firm Wockhardt is recalling 1,62,142 cartons of various drugs, which are used to treat ailments like high blood pressure…

Updated: July 17, 2015 11:32 IST

Loading…

Something went wrong. Please refresh the page and/or try again.